Genmab opjusterer prognose efter japansk milepæl

Biotekselskabet Genmab har fået 25 mio. dollar fra sin amerikanske partner Janssen Pharmaceuticals, efter at partneren har foretaget det første salg af kræftmidlet Darzalex på det japanske marked.

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

You must be logged in to post a comment.

Powered by WordPress | Designed by: Premium Themes | Thanks to Free WordPress 4 Themes, Download Premium WordPress Themes and
%d bloggers like this: